— RHEUMATOLOGY CLINICAL STUDIES
World Research Link evaluates emerging target therapies for auto-immune and chronic inflammatory conditions. Browse active rheumatology protocols currently accepting participant applications across our site network.
ABBVIE
SANOFI
TAKEDA
Moderate-to-severe systemic lupus erythematosus
Early polymyalgia rheumatica; sarilumab
Psoriatic arthritis per invitation code; verify
Protocol M23-699 / SELECT-SLE
Trial Phase: 3
Protocol EFC18055
Trial Phase: 4
Protocol TAK-279-PsA-3004
Trial Phase: 3
Begin the onboarding process
We respond to all sponsor, physician, and patient inquiries within one business day. Our structured onboarding process ensures rapid site activation and rigorous compliance from day one.
Community-embedded research sites
Our trial network spans multiple community clinics, bringing advanced clinical trials directly to local patient populations. We integrate research seamlessly into trusted, everyday healthcare environments.
Central Coordination
Our centralized headquarters manages regulatory compliance, staff training, and trial logistics, keeping the burden off local physicians.
Site Feasibility
We rapidly assess local clinic patient panels to match complex sponsor protocols with highly qualified, community-embedded medical practices.